Advantages and disadvantages of early orchidopexy

Zacharias Zachariou

Medical School, University of Cyprus, Nicosia, Cyprus.

Correspondence; Prof Dr med PhD em. Zacharias Zachariou University of Cyprus, Nicosia, Cyprus.

Table of contents

Abstract
Résumé
Paper
References
Author

Abstract

The optimal timing of orchidopexy for cryptorchidism remains debated despite guidelines favoring repair between 6–12 months; this narrative synthesis integrates histologic, endocrine, and clinical outcome data — framed by the symposium transcript from Vassalli Hall — to evaluate the advantages and disadvantages of early surgery. Earlier orchidopexy (≤12 months) is consistently associated with better postoperative testicular growth and germ-cell preservation, with surrogate markers of fertility (germ-cell counts, semen parameters) generally superior to those seen after delayed repair. However, recent series show comparable rates of testicular atrophy and perioperative complications across early and later cohorts in experienced hands.

Countervailing considerations include the possibility of intrinsic, irreversible testicular defects that limit benefit, technical and anesthetic challenges in smaller infants, and the risk of unnecessary operations stemming from diagnostic inaccuracy, all compounded by persistent real-world delays that undermine adherence to early-repair guidance. Overall, the weight of evidence supports early orchidopexy — ideally between 6 and 12 months — as the strategy most likely to preserve testicular tissue and enhance future fertility without increasing operative risk, while emphasizing individualized planning for high intra-abdominal testes and the need for standardized outcomes and long-term fertility (live-birth) endpoints to definitively quantify benefit.

Key words Cryptorchidism, early orchidopexy, strategy

Résumé

Le moment optimal de l’orchidopexie pour le traitement de la cryptorchidie demeure débattu, bien que les recommandations actuelles privilégient une intervention entre 6 et 12 mois ; cette synthèse narrative, intégrant les données histologiques, endocriniennes et cliniques — et s’appuyant sur le discours du symposium de Vassalli Hall — évalue les avantages et les inconvénients d’une chirurgie précoce. Orchidopexie réalisée avant l’âge de 12 mois est systématiquement associée à une meilleure croissance testiculaire postopératoire et à une préservation accrue des cellules germinales, avec des marqueurs substitutifs de fertilité (nombre de cellules germinales, paramètres spermatiques) supérieurs à ceux observés après une correction plus tardive.

Cependant, tandis que les taux d’atrophie testiculaire et de complications opératoires demeurent comparables entre les groupes, dans les séries récent menées par des équipes expérimentées ; les arguments contraires incluent la possibilité de lésions testiculaires intrinsèques et irréversibles limitant le bénéfice, les difficultés techniques et anesthésiques propres aux nourrissons, ainsi que le risque d’interventions inutiles liées à des erreurs diagnostiques, le tout aggravé par des retards persistants dans la prise en charge qui compromettent l’application des recommandations ; dans l’ensemble. Les données disponibles soutiennent l’orchidopexie précoce — idéalement entre 6 et 12 mois — comme la stratégie la plus à même de préserver le tissu testiculaire et d’améliorer la fertilité future sans accroître le risque opératoire, tout en soulignant la nécessité d’une approche individualisée pour les testicules intra-abdominaux hauts et d’études à long terme standardisées portant sur la fertilité (naissances vivantes) afin de quantifier de façon définitive le bénéfice.

Mots-clés: Cryptorchidie, orchidopéxie précoce, stratégie

Open slides

Introduction: Cryptorchidism, histopathology, and rationale for surgical correction

Definitions, epidemiology, and natural history

Cryptorchidism (undescended testis, UDT) is defined as failure of one or both testes to descend into the scrotum by birth or within early infancy. It is one of the most common congenital anomalies encountered in pediatric urology/andrology, with a birth prevalence generally of about 2–5% in full-term male infants, and higher among preterm infants (estimates up to ~30%). [1]. Many testicles will descend spontaneously in the first few months of life (especially by 3–6 months), after which spontaneous descent is rare. [2]. After 6 months, ongoing spontaneous descent is unusual; thus, persistent cryptorchidism beyond 6–12 months prompts evaluation for surgical correction. [3].

Cryptorchidism may be unilateral or bilateral and may present in different anatomical locations: intra-abdominal, inguinal canal, suprascrotal, or at the external inguinal ring. Nonpalpable testes (often intra-abdominal) may require imaging or laparoscopy to be localized. [2]. Some testes may be retractile (i.e. normally descend into scrotum with manipulation) or ascending (initially descended but later ascend). Distinguishing retractile from true undescended testes is important. [2].

Risk factors for cryptorchidism include prematurity, low birth weight, genetic predisposition, androgen-insensitivity or hormonal defects, environmental endocrine disruptors, and maternal factors. [2].

Left untreated, cryptorchidism is associated with risks including impaired spermatogenesis/fertility, testicular atrophy, increased risk of testicular malignancy, torsion risk, and inguinal hernia [2,4].

Histopathology and progression of testicular degeneration

One of the key rationales for early surgical intervention is the histologic and cellular damage that accrues over time in an undescended testis exposed to higher-than-scrotal temperatures and perhaps abnormal endocrine or paracrine milieu.

  • Germ cell depletion and apoptosis. Multiple studies have documented a decline in germ cell (including spermatogonia) number and quality over time in undescended testes. After the first year of life, a progressive loss of germ cells may occur, reducing the population of stem spermatogonia and impairing future spermatogenesis. [5].
  • Morphological changes in seminiferous tubules. In prolonged undescended testes, histologic features may include thickening of the basement membrane, interstitial fibrosis, loss or degeneration of germinal epithelium, Leydig cell changes, and reduced tubular diameter. [2].
  • Impaired hormonal milieu. The undescended testis may suffer from microenvironmental disturbances, altered temperature regulation, oxidative stress, or local endocrine dysregulation — potentially influencing Leydig cell function, Sertoli cell function, or paracrine support for spermatogenesis. [2].
  • Irreversibility over The longer the gonadal tissue remains undescended, the more likely that degenerative changes become irreversible, limiting the restorative potential of surgery [6].

These pathophysiologic insights motivate the idea that earlier relocation of the testis to the cooler scrotal environment may halt or partially reverse damage, preserve germ cells, and optimize fertility potential.

Goals and aims of orchidopexy

The aims of orchidopexy can be summarized (and critiqued) as follows:

  1. Prevent or reduce testicular atrophy
  2. Preserve or improve spermatogenic capacity / fertility potential
  3. Prevent further deterioration
  4. Minimize complications (vascular injury, vas deferens damage)
  5. Reduce long-term risks, g. malignancy
  6. Correct anatomical position for monitoring, maintenance

In surgical practice, choices of technique (open vs laparoscopic, Fowler-Stephens stages, gubernaculum-sparing, microvascular anastomosis, etc.) and timing must be aligned with those aims and balanced with the risks.

Thus, the question of timing — and specifically whether early orchidopexy confers net advantage over later surgery — remains central and somewhat unsettled in the literature.

Definition of “early orchidopexy” and guideline recommendations

Before delving into pros and cons, it is essential to define what is meant by “early orchidopexy” and to understand international guideline consensus (or lack thereof) on the timing.

What is “early”?

In the literature, “early” orchidopexy is variably defined but generally refers to relocation of the undescended testis before 12 months of age — often between 6 and 12 months. Some authors push even earlier (before 6 months), though this is less common and not universally accepted. [2,7]. Some comparative studies group operations by age (e.g., ≤12 months vs >12 months) to compare outcomes. [5].

In practice, many centers historically delayed orchidopexy to later infancy, toddler age, or even childhood (e.g. age 2–3 years), but more recent guidelines have increasingly recommended earlier intervention. [3].

Some recent analyses use metrics like growth percentage ratio (GPR) to compare testicular growth relative to contralateral testis, stratified by timing of surgery. [1].

Key guideline recommendations and practice surveys

  • The European Association of Urology / European Society for Pediatric Urology (EAU/ESPU) Guidelines for management of undescended testes typically recommend orchidopexy ideally between 6 and 12 months, and certainly by 18 months of age at latest.
  • AUA (American Urological Association) / pediatric urology guidelines tend to similarly favor early referral and surgery (though practices vary). [8].
  • Many observational surveys show that actual practice often lags guideline ideal: few orchidopexies are conducted before 12 months of age, even a decade after guidelines exist. For instance, a German national analysis reported only 15% of hospital patients underwent orchidopexy before age 1, and only 5% in private practice did so, even 10 years after guideline publication. [3].
  • The study “Are we still too late? Timing of orchidopexy” observed persistently low rates of early orchidopexy, prompting calls for increased awareness and adherence. [3].
  • A Greek observational single-center study echoed that guidelines generally recommend corrective surgery by 12 months and no later than 18 months, yet many patients are operated later. [9].
  • The “Nordic consensus on treatment of undescended testes” recommends preferably surgical treatment and not in general hormonal treatment between 6 and 12 months of age, or upon The “Nordic consensus on treatment of undescended testes” recom-mends preferably surgical treatment and not in general hormonal treatment between 6 and 12 months of age, or upon diagnosis. [10].
  • The European Society for Pediatric Urology Guidelines state that there is good evidence for early correction of undescended testes preventing potential impairment of fertility and reduce the risk of testicular malignancy. No consensus exists on the various forms of hormonal treatment, which are assessed on an individual basis. [11].

Thus, while there is growing consensus recommending early surgery (preferably before or around 12 months), real-world adherence remains suboptimal, and there remains debate about the exact “optimal” cutoff.

Advantages of early orchidopexy

Here we consider the potential benefits — supported by molecular, histologic, imaging, endocrine, and clinical evidence — of performing orchidopexy at an earlier age.

Preservation of germ cell number and quality

One of the strongest arguments for early surgery is that relocating the gonad earlier limits the ongoing loss of germ cells and may preserve the stem spermatogonial pool:

  • Multiple histologic studies show that germ cell counts decline with age in undescended testes, so earlier relocation might “catch” the testis before irreversible depletion. [2].
  • Some studies show that earlier surgery is correlated with less severe germ cell loss and better germ cell maturation indices. For instance, meta-analyses suggest fertility potential may be better in early orchidopexy groups. [6].
  • The systematic review and meta-analysis referenced in the literature concluded that although atrophy and complication rates may not differ between early and delayed orchidopexy, early surgery may offer better fertility potential. [6].
  • The retrospective study of orchiopexy within 1 year vs later showed that earlier intervention significantly accelerates growth of the undescended testis, using a new metric GPR (growth percentage ratio). The early group had GPR ~2.02 compared to ~1.25 in older groups. [1].

Thus, by decreasing the exposure time of the testis to a suboptimal environment, early surgery might preserve more germ cell reserves and improve the “starting point” for future spermatogenesis.

Improved testicular growth / volume retention

Another measurable objective is preserving testicular size and volume:

  • The study from Nature (2017) reported that boys undergoing orchiopexy under 1 year demonstrated significantly higher GPR than those operated later, implying that earlier surgery supports better catch-up growth of the undescended testis relative to the contralateral testis. [1].
  • More broadly, a systematic review (2025) on testicular atrophy and growth found that earlier management correlates with better growth outcomes, while delayed surgery is associated with greater risk of volume loss [12].
  • The logic is that early repositioning to cooler scrotal environment helps restore more normal physiology, permitting better recovery or continued growth, whereas prolonged delay allows atrophy or fibrosis to set in.

Better fertility / spermatogenesis outcomes

Since the ultimate functional goal is fertility, the question is whether early surgery leads to better adult spermatogenesis:

  • Some meta-analyses and systematic reviews suggest that early orchidopexy is associated with increased sperm counts and better semen parameters compared to delayed surgery. [6].
  • One review argued that fertility potential “may be better with early orchidopexy.” [6].
  • In bilateral cryptorchidism, the risk of infertility is highest; early bilateral correction may optimize residual testicular function. [2].
  • Even in unilateral cases, early correction may reduce the “second hit” on the contralateral testis or limit hormonal crosstalk Some authors argue that unilateral cryptorchidism still carries some subtle fertility reduction, so early surgery may mitigate that. [2].

Though the literature is not uniform, the trend across multiple observational and meta-analytic works leans toward better fertility outcomes with earlier surgery.

Prevention of further deterioration and irreversible damage

Early orchidopexy may help arrest or slow the progression of damage:

  • It may prevent further germ cell loss, fibrosis, or interstitial changes that accumulate over time, thus preserving tissue structure before irreversible degeneration. [2].
  • By intervening earlier, one may mitigate secondary insults due to heat, oxidative stress, vascular compromise, or microenvironmental disturbances.
  • Surgeons often reason that “damage may be reversible early but not late,” so earlier intervention gives more “room” for recovery. This aligns with Vassalli Hall’s emphasis that we want to “prevent further deterioration.”

Potential reduction of malignancy risk / earlier surveillance

Although the evidence is less definitive, early orchidopexy might influence long-term risks:

  • Undescended testis is a known risk factor for testicular germ-cell tumors (about 4–40× increased relative risk). [4].
  • Some epidemiologic data suggest that earlier orchidopexy (before puberty or before age 10) may reduce cancer risk more than later correction. [2].
  • Early placement in the scrotum allows for easier surveillance (palpation, ultrasound) and earlier detection of any neoplastic changes.

Psychological, anatomical, and practical benefits

Other practical or secondary benefits include:

  • A testis in the scrotum is more accessible for examination, palpation, monitoring, and self-examination in the future.
  • Anatomical repositioning at an earlier age may reduce the risk of future torsion or associated hernia.
  • Earlier surgery may minimize the period during which the child and family deal with the anxiety or uncertainty of undescended testis.
  • From a logistical standpoint, earlier repair may integrate with other pediatric care schedules and prevent backlog or delays in surgical waitlists.

Disadvantages, risks, and counterarguments of early orchidopexy

While early surgery has many theoretical and empirical advantages, it also carries potential downsides, uncertainties, or trade-offs.

Surgical risks (vascular, vas modeling, anesthesia concerns)

  • Vascular injury and testicular atrophy. In a small infant, the testicular vessels may be shorter or more delicate; dissection and mobilization carry risk of devascularization or microvascular compromise leading to testicular atrophy. Vassalli Hall himself mentions “damage of the blood vessels” in the transcript.
  • Damage to vas deferens. The vas and its blood supply may be at higher relative risk in very young patients.
  • Technical difficulty. The smaller anatomical size, fine tissues, and fragility may make surgery more technically demanding.
  • Anesthesia risk. Infants under 6 or 12 months may have higher anesthetic risk, though modern pediatric anesthesia has reduced this significantly. [13].
  • Overtreatment / unnecessary surgery. If spontaneous descent would have occurred (rare beyond 6 months), early intervention might represent overtreatment, though that is less of a concern if one enforces a minimal observation period.

Lack of solid randomized controlled trial evidence and bias

  • Much of the literature is observational, retrospective, or heterogeneous in design, limiting the strength of causal inferences.
  • Confounding factors (e.g. selection bias, surgical skill, follow-up duration, baseline testis health) may bias results. Vassalli Hall remarks: “all the studies … are biased by one or other way” (transcript).
  • There is no universally accepted standard or protocol for measuring outcomes (germ cell counts, testis volume, fertility endpoints) which complicates comparative assessment.

Diminishing returns if testicular pathology is already present

  • In some cases, testicular pathology (germ cell loss, fibrosis) may already have occurred prenatally or very early Earlier surgery may not reverse such intrinsic damage.
  • If the undescended testis is already severely compromised, early orchidopexy may not improve fertility outcomes meaningfully.

Technical limitations and anatomical constraints

  • In some nonpalpable or high intra-abdominal testes, surgical techniques (e.g. staged Fowler-Stephens) require more complex planning; doing them very early may limit surgical options or increase risk.
  • The length of the cord, vascular length, and risk of tension or traction injury may be more challenging in infants.
  • In cases where the testis is located too far from the internal ring, or vascular length is insufficient, staged procedures or more advanced microvascular techniques may be necessary, and timing must be carefully

Potential for unnecessary surgery in misdiagnosed cases

  • Some children may have initially apparent undescended testis that would descend spontaneously within early months; early surgery may be performed in error or
  • In the transcript, Vassalli Hall cautions that “a lot of these children are operated, actually, without having an undescended ” This suggests overdiagnosis or overzealous surgical referral may lead to unnecessary interventions.

Follow-up challenges and long-term proof limitations

  • The ultimate proof of fertility is the ability to father a Many studies do not have long-term follow-up into adulthood, making it hard to confirm that early surgery yields higher live birth rates.
  • Differences in follow-up duration, drop-out rates, and inconsistent outcome measurement hamper comparability.

Synthesis of evidence: what the data says

Atrophy and complication rates

The systematic review and meta-analysis comparing early vs late orchidopexy found that atrophy and complication rates do not appear significantly different between early and delayed surgery, but fertility potential may trend better with earlier repair. [6]. This suggests that early timing does not increase surgical morbidity, supporting the safety of early intervention.

Testicular growth metrics

As noted above, the study using growth percentage ratio (GPR) showed significantly better post-operative growth when orchidopexy is done under 1 year, compared to older ages. [1]. A more recent review also confirms that earlier management is correlated with better testicular growth. [1,12,14].

These indicate that early orchidopexy confers measurable improvements in testicular volume/size metrics.

Fertility and spermatogenesis outcomes

Literature is less uniform in this domain, but umulative evidence trends toward a benefit:

  • Some studies report of improved sperm counts or semen parameters in early orchidopexy
  • The caveat is that many studies are small, retrospective, or vulnerable to selection bias or confounding by surgeon skill, pathology severity, or duration of follow-up.
  • Bilateral cryptorchidism remains a high-risk scenario where outcomes are more consistently poor; early correction may at least maximize residual function. [15].
  • One study “Fertility potential in adult men treated for uncorrected bilateral…” emphasizes that earlier correction is broadly considered beneficial, although residual impairment may persist. [15].

Ultimately, although early orchidopexy does not guarantee fertility normalization, it likely improves the odds compared to delayed repair.

Practice versus guideline adherence

Despite increasing consensus on early repair, actual practice continues to lag. The German national data (15% in hospital, 5% private before age 1) exemplifies this. [3]. (SpringerLink) Similar patterns have been observed in other countries. [2]. Reasons include delayed referral, lack of awareness, scheduling delays, or resource constraints.

Gaps, controversies, and uncertainty

  • The absence of randomized controlled trials comparing early vs delayed surgery limits level I evidence.
  • Heterogeneity in study designs, surgical techniques, follow-up, and outcome definitions muddy conclusions.
  • The threshold of how “early” is optimal remains debated (e.g., before 6 months vs within 12 months).
  • In high intra-abdominal testes or cases requiring complex surgical strategies, the timing question becomes even more nuanced.
  • The intrinsic baseline pathology (prenatal damage, genetic defects) may limit the benefit of timing.
  • Long-term fertility endpoints (live births) are rarely studied, and many studies rely on surrogate markers (germ cell counts, semen parameters).

Practical recommendations and “balanced view”

Given the above, what practical guidance or balanced stance can be advanced?

Suggested optimal timing

  • Based on current evidence and guideline consensus, orchidopexy is ideally performed between6and12monthsofage, while delaying beyond 18 months is suboptimal.
  • If surgical logistics permit, earlier in that window (closer to 6 months) may yield slightly better growth or germ cell preservation, but trade-offs (anesthesia, surgical risk) must be considered
  • For very high intra-abdominal testes or when complex staged procedures are anticipated, timing may be individualized.

Decision framework considerations

When deciding timing, the surgeon/endocrinologist should weigh:

    1. Baseline status of the testis (palpable vs nonpalpable, vascular length, location)
    2. Surgical risk and feasibility (can the testis be mobilized safely at that age?)
    3. Anesthetic risk and institutional capability
    4. Potential for spontaneous descent (typically negligible beyond 6 months)
    5. Surveillance logistics and referral delays
    6. Familial preferences and psychosocial factors

Technique and surgical strategy alignment

  • Early surgery does not mandate inferior techniques; experienced centers can use microdissection, microsurgical techniques, and minimal-invasive approaches to reduce risks.
  • In cases where early relocation is not feasible anatomically (e.g. short vessels), a staged or modified approach (e.g. Fowler-Stephens, Shehata technique) might be appropriate, even if at slight delay. [2].
  • Preservation of the gubernaculum, use of laparoscopy, and gentle handling can mitigate surgical risk even in younger infants. [5].

Monitoring and long-term follow-up

  • Rigorous follow-up, including serial ultrasound, hormonal evaluation, sperm parameter analysis (when of age), and clinical surveillance is essential to assess outcomes.
  • Central registries or prospective cohorts would help strengthen evidence.
  • Longitudinal tracking into adult fertility outcomes, including paternity data, is crucial to better define ultimate benefit.

Acknowledging uncertainty and individualization

  • Surgeons and clinicians must acknowledge that not every child will achieve “normal” fertility despite early surgery, due to intrinsic damage or unknown factors.
  • Timing decisions should be made in multidisciplinary settings (surgeon, endocrinologist, pediatric urologist) with shared decision-making with families.
  • In the face of resource constraints or scheduling delays, earlier prioritization of cryptorchid cases is justified based on potential benefit.

Integration with the transcript and thematic commentary

The transcript from Vassalli Hall offers several relevant reflections and significant facts, which we can overlay on this evidence-based discussion:

  • He underscores the fundamental aims of orchidopexy (prevent atrophy, preserve fertility, avoid damage) and the challenges of surgical technique, vascular risk, and vas injury.
  • His rhetorical question, “When should we do the operation?” mirrors the crux of this paper.
  • He notes that historically, surgeries were done later (e.g. around 10 years of age in the 1950s), but gradually timing has shifted toward earlier ages (e.g. 6 months).
  • He cautions that many operations are performed even without a true undescended testis, indicating diagnostic overreach—this warns us to be prudent in patient selection.
  • He emphasizes that literature comparing early vs late is sparse and biased, and that endocrine and molecular biologists must help answer when is optimal (rather than surgeons operating blindly).
  • He expresses uncertainty: “Is it conclusive that delayed surgery … equals decreased fertility potential? We don’t know.”
  • He also raises the question of reversibility and inherent defects: if a testis is already pathologic, early relocation may not suffice.

These points highlight that while clinical and surgical mats exist, the truly firm answers remain elusive, reinforcing that a cautious but proactive stance is optimal.

Limitations, gaps, and future research directions

  • To drive forward progress in the field, future research should address:
  • Prospective, ideally randomized, trials of early vs delayed orchidopexy (though ethical/logistical barriers exist)
  • Standardization of outcomes, including germ cell counts, testicular volume measures, semen parameters, and long-term fertility endpoints
  • Long-term follow-up cohorts tracking live birth/paternity, hormonal function, malignancy incidence
  • Molecular and biomarker studies to identify which testes are more salvageable —
  • e.g. genomic, proteomic markers, testicular microenvironment signatures
  • Imaging and noninvasive assessments predicting viability and “reserve” preoperatively
  • Refinement of surgical techniques (microsurgery, vascular-sparing, novel traction-based approaches) tailored to younger patients
  • Health services and implementation studies to reduce delays and increase guideline adherence
  • Cost-benefit, risk-benefit modeling incorporating anesthesia risk, surgical resource allocation, long-term outcomes

By bridging molecular, endocrine, and surgical perspectives (exactly in line with the symposium thematic), future consensus on optimal timing may emerge.

Conclusion

Declaration Section

  1. Ethics Approval and Consent to Participate Investigations were carried out in accordance 326 with the Declaration of Helsinki of 1975, revised in 2008.
  2. Consent for publication Not applicable
  3. Availability of data and supporting material Not applicable
  4. Competing interests Author/s declare that they have no competing interests
  5. Funding No financial

References

  1. Chi-Shin T, I-Ni C, Chung-Hung H, Yu-Chuan L, Jian-Hua H, Hong-Chiang C et al. Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle. Nature Sci Rep. 2017; 12,7(1) doi.org/10.1038/s41598-017-17825-w
  2. Jie L, Wenli X, Bangzhi S, Zhiyuan J, Xudong X, Nan X, Guangqi D. Open controversies on the treatment of undescended testis: An update. Front Pediatr . 2022;10:874995 doi: 10.3389/fped.2022.874995.
  3. Schmedding A, van Wasen F, Lippert R. Are we still too late? Timing of orchidopexy. Eur J Pediatr. 2023; 182:1221-1227 doi: 10.1007/s00431-022-04769-1.
  4. Giwercman A, Bruun E, Frimodt-Møller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol. 1989;142: 998–1001 doi: 10.1016/s0022-5347(17)38967-x.
  5. Pakkasjärvi N , Taskinen S. Surgical treatment of cryptorchidism: current insights and future directions. Front Endocrinol 2024;15:1327957 doi: 10.3389/fendo.2024.1327957
  6. Allin BSR, Dumann E, Fawkner-Corbett D, Kwok C Skerritt C. Systematic review and meta-analysis comparing outcomes following orchidopexy for cryptorchidism before or after 1 year of age. BJS 2018; 2:1–12 doi: 10.1002/bjs5.36.
  7. Hadziselimovic F, Herzog B. The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet 2001; 358: 1156–1157 doi: 10.1016/S0140-6736(01)06274-2.
  8. Kolon TF, Herndon CD, Baker LA, Baskin LS, Baxter CG, Cheng EY, et al. Evaluation and treatment of cryptorchidism: AUA guideline. J Urol. 2014;192:337–45. Revised and confirmed 2025 doi: 10.1016/j.juro.2014.05.005.
  9. Kaselas C, Florou M, Tirta M, Bitzika S, Sidiropoulou D, Spyridakis I. The Time of Diagnosis and Surgical Treatment of Congenital Cryptorchidism: A Single Center’s Observational Study in Greece. Cureus. 2024;16: e51580 doi: 10.7759/cureus.51580.
  10. Ritzen EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, et al. Nordic consensus on treatment of undescended testes. Acta Pediatric. 2007; 96:638–43 doi: 10.1111/j.1651-2227.2006.00159.x
  11. Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Stein R et al. Management of undescended testes: European Association of Urology/European Society for Pediatric Urology Guidelines. J Pediatr Urol. 2016;12: 335–343 doi: 10.1016/j.jpurol.2016.07.014.
  12. Faisal FA, Badr MR, Leen MA, Mohammed MB, Lena MA, Baraa BM, Jehad HH, Ali AA, Abdullah M. Testicular atrophy and growth post orchidopexy in pediatric patients. Journal Pediatric Surgery. 2025;100205 doi.org/10.1016/j.yjpso.2025.100205
  13. Davidson AJ, Disma N, de Graaff JC, Withington DE, Dorris L, Bell G et al; GAS consortium. Neurodevelopmental outcome at 2 years of age after general anesthesia and awake-regional anesthesia in infancy (GAS): an international multicenter, randomized controlled trial. Lancet 2016; 387: 239–250 doi: 10.1016/S0140-6736(15)00608-X
  14. Kollin C, Granholm T, Nordenskjöld A, Ritzén Growth of spontaneously descended and surgically treated testes during early childhood. Pediatrics 2013; 131: e1174–e1180 doi: 10.1542/peds.2012-2902.
  15. Muncey W, Dutta R, Terlecki RP, Woo LL, Scarberry Fertility potential in adult men treated for uncorrected bilateral cryptorchidism — gender. A systematic literature review and analysis of case reports. Andrology 2021; 9(3):781-791 doi: 10.1111/andr.12964.

 

Zacharias Zachariou

Lorem ipsum dolor sit amet consectetur. Id mollis nulla maecenas at vestibulum blandit consectetur. Vulputate libero turpis diam eu rhoncus arcu. Donec at imperdiet viverra ut eu sagittis nunc volutpat. Sem nisi turpis venenatis non sed adipiscing donec dignissim.